• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Study suggests role for adenosine in molecular processes involved in epilepsy
Silk has walked straight off the runway and into the lab. According to a new study published in the Journal of Clinical Investigation, silk implants placed in the brain of laboratory animals and designed to release a specific chemical, adenosine, may help stop the progression of epilepsy. The research was supported by the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB), which are part of the National Institutes of Health...
Source: Health News from Medical News Today - July 29, 2013 Category: Consumer Health News Tags: Epilepsy Source Type: news

Quickly clearing away damaged proteins may help prevent neurodegenerative disorders
Recycling is not only good for the environment, it's good for the brain. A study using rat cells indicates that quickly clearing out defective proteins in the brain may prevent loss of brain cells. Results of a study in Nature Chemical Biology suggest that the speed at which damaged proteins are cleared from neurons may affect cell survival and may explain why some cells are targeted for death in neurodegenerative disorders. The research was supported by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health...
Source: Health News from Medical News Today - July 24, 2013 Category: Consumer Health News Tags: Huntingtons Disease Source Type: news

Heart And Stroke Risk Tests Can Predict Dementia Risk
Evaluating a person's future risk of heart disease and stroke may be a better predictor of mental decline than a dementia risk test. The finding came from new research published in the journal Neurology, the medical journal of the American Academy of Neurology. "This is the first study that compares these risk scores with a dementia risk score to study decline in cognitive abilities 10 years later," said Sara Kaffashian, PhD, with the French National Institute of Health and Medical Research (INSERM) in Paris, France...
Source: Health News from Medical News Today - April 2, 2013 Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news

National NIH Collaboration To Find Parkinson's Biomarkers And Open Vast Data Sharing Opportunities
Last month, the National Institutes of Health announced a new collaborative initiative that aims to accelerate the search for biomarkers -- changes in the body that can be used to predict, diagnose or monitor a disease -- in Parkinson's disease, in part by improving collaboration among researchers and helping patients get involved in clinical studies. As part of this program, launched by the National Institute of Neurological Disorders and Stroke (NINDS), part of the NIH, Clemens Scherzer, MD, a neurologist and researcher at Brigham and Women's Hospital (BWH), was awarded $2...
Source: Health News from Medical News Today - March 12, 2013 Category: Consumer Health News Tags: Parkinson's Disease Source Type: news

Study Assessed Benefits Of Targeted Clot Removal Based On Brain Status
The use of advanced imaging shortly after the onset of acute stroke failed to identify a subgroup of patients who could benefit from a clot-removal procedure, a study has found. The randomized controlled trial known as Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) was funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, and was published online in the New England Journal of Medicine...
Source: Health News from Medical News Today - February 12, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Stroke-Related Disability Not Improved By Clot-Retrieval Devices
A stroke survivor's chances of living independently after 90 days are not improved by the use of devices inserted into the artery to dissolve or remove a stroke-causing clot shortly after the onset of symptoms, according to a randomized controlled trial involving 656 patients. The study, funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, compared the intra-arterial device-based approach plus the current standard of intravenous (IV) tissue plasminogen activator (t-PA), a clot-busting drug with IV t-PA therapy alone...
Source: Health News from Medical News Today - February 11, 2013 Category: Consumer Health News Tags: Stroke Source Type: news